The management of renal cell carcinoma

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P A PalmerC R Franks

Embolisation in the management of peripancreatic pseudoaneurysm--a case report

Feb 1, 1992·Australasian Radiology·S Kolt, A Wise

A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.

Jan 1, 1992·Journal of Immunotherapy·J SkillingsB Weinerman

Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H von der MaaseL Israel

Phase I evaluation of recombinant tumor necrosis factor given in combination with recombinant interferon-gamma

Oct 1, 1991·Journal of Immunotherapy·J W SmithR G Steis

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4

Nov 1, 1991·Science·P T GolumbekD M Pardoll

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA.

Jan 21, 1991·International Journal of Cancer. Journal International Du Cancer·S J RussellM K Collins

Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.

Jan 1, 1991·Oncology·O KokronP R Schmidt

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

May 1, 1991·The Journal of Experimental Medicine·T BlankensteinT Diamantstein

Cancer causes and control

Jul 1, 1990·Cancer Causes & Control : CCC·B Mac Mahon

Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump

Jul 15, 1990·Cancer·B DamascelliG Comeri

High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma

Jul 18, 1990·Journal of the National Cancer Institute·J S AbramsM J Hawkins

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

Oct 1, 1990·The Journal of Experimental Medicine·B GansbacherE Gilboa

Renal cell adenocarcinoma associated with AIDS-related Kaposi's sarcoma

Aug 1, 1990·AIDS·A Azón-MasoliverJ M Mascaró

Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group study

Jan 17, 1990·Journal of the National Cancer Institute·R M BukowskiR P Whitehead

Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma

Sep 5, 1990·Journal of the National Cancer Institute·E R GaynorJ H Doroshow

Interferon therapy in disseminated renal cell carcinoma

Aug 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F EdsmyrH Strander

Radiation therapy in the treatment of metastatic renal cell carcinoma

Nov 1, 1985·International Journal of Radiation Oncology, Biology, Physics·V Onufrey, M Mohiuddin

Regulation of cell growth by interferon

Jan 1, 1987·Cancer Metastasis Reviews·M Shearer, J Taylor-Papadimitriou

Therapy of chronic myelogenous leukemia with interferon.

Jan 1, 1989·Cancer Investigation·R KurzrockM Talpaz

Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma

Feb 1, 1989·American Journal of Clinical Oncology·M R SertoliR Rosso

Cyclic interferon gamma treatment of patients with metastatic renal carcinoma

Sep 1, 1989·British Journal of Urology·J W Grups, H G Frohmüller

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

Mar 18, 1989·Lancet·R L KradinR J Callahan

Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma.

Feb 1, 1989·British Journal of Urology·R T OliverJ M Bottomley

Specific genetic change in tumors associated with von Hippel-Lindau disease

Jul 19, 1989·Journal of the National Cancer Institute·K ToryF F Marshall

Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients.

Jun 1, 1989·Cancer Treatment Reviews·T PhilipJ T Bijmann

Atypical cysts and carcinomas of the kidneys in the phacomatoses. A quantitative DNA study using static and flow cytometry

Jan 1, 1989·Cancer·R E IbrahimN Weidner

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.

Jan 1, 1988·Journal of Cancer Research and Clinical Oncology·F PorzsoltH Rasche

Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses

Jan 1, 1988·Seminars in Surgical Oncology·G L CettoG de Sandre

Phase II study of recombinant human interferon gamma (S-6810) on renal cell carcinoma. Summary of two collaborative studies. Recombinant Human Interferon Gamma (S-6810) Research Group on Renal Cell Carcinoma

Sep 1, 1987·Cancer

Alpha and gamma interferon in the treatment of advanced renal cell carcinoma

Jan 1, 1988·Seminars in Surgical Oncology·A D GeboersO Damsma

Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis

Jan 1, 1988·Seminars in Surgical Oncology·A de ForgesJ P Droz

Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial

Apr 1, 1988·Annals of Internal Medicine·R I FisherK A Margolin

Phase I study of recombinant human tumor necrosis factor

Jan 1, 1987·Cancer Chemotherapy and Pharmacology·K KimuraH Majima

The epidemiology of testicular cancer

Oct 1, 1987·British Journal of Urology·Y D Senturia

Combination of interferon and prednisone in human cancer

Apr 1, 1988·European Journal of Cancer & Clinical Oncology·E A Abdi

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

Apr 9, 1987·The New England Journal of Medicine·S A RosenbergJ T Rubin

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

Apr 9, 1987·The New England Journal of Medicine·W H WestR K Oldham

Renal carcinoma after retrograde pyelography with Thorotrast

May 1, 1987·AJR. American Journal of Roentgenology·D KauzlaricM Petrovic

Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature

May 1, 1986·Cancer·P N BretanR D Williams

Asbestos and renal adenocarcinoma: a case-control study

Apr 1, 1987·Environmental Research·M Maclure

❮ Previous

Next ❯

Citations

A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin

Dec 31, 1997·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·H HadidiS Cholerton

Interferon-alpha and survival in renal cell cancer

Sep 1, 1995·British Journal of Urology·S FossaP Selby

Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil

Jul 1, 1996·The Journal of Urology·G HofmockelH G Frohmüller

Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study

Sep 11, 2001·Cancer·M KankuriE Salminen

Palpable splenomegaly in children with haemoglobin SC disease: haematological and clinical manifestations

Aug 10, 2000·Clinical and Laboratory Haematology·S A Zimmerman, R E Ware

Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches

Oct 12, 2010·Journal of Biomedicine & Biotechnology·Chary López-PedreraMaria José Cuadrado

Cytokines affect resistance of human renal tumour cells to complement-mediated injury

Jun 7, 2003·Scandinavian Journal of Immunology·V T BlokA Gorter

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage

Apr 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·V T BlokA Gorter